Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event.

MLA

Ye, Carrie, et al. “Fracture Rate Increases after Immune Checkpoint Inhibitor Treatment: A Potential New Immune Related Adverse Event.” Osteoporosis International, vol. 34, no. 4, Apr. 2023, pp. 735–40. EBSCOhost, https://doi.org/10.1007/s00198-023-06690-1.

APA

Ye, C., Lee, K., Leslie, W. D., Lin, M., Walker, J., & Kolinsky, M. (2023). Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event. Osteoporosis International, 34(4), 735–740. https://doi.org/10.1007/s00198-023-06690-1

Chicago

Ye, Carrie, Kevin Lee, William D. Leslie, Mu Lin, John Walker, and Michael Kolinsky. 2023. “Fracture Rate Increases after Immune Checkpoint Inhibitor Treatment: A Potential New Immune Related Adverse Event.” Osteoporosis International 34 (4): 735–40. doi:10.1007/s00198-023-06690-1.